Generated by AI
First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded fund (ETF) that primarily tracks the performance of the NYSE Arca Biotechnology Index. Designed to provide investors exposure to the biotechnology sector, this ETF includes companies involved in the research, development, and manufacture of various therapeutics and medical treatments. Its primary function is to provide liquidity and diversification, allowing investors to gain access to a wide array of biotechnology companies through a single financial instrument. The fund comprises a basket of stocks from prominent biotechnology companies, reflecting the dynamic and innovative nature of this sector. Given the rising demand for advanced medical solutions, this ETF plays a critical role in the financial markets by enabling investors to capitalize on the growth potential within the biotech industry. Furthermore, it actively impacts sectors such as pharmaceuticals, healthcare, and life sciences. By spreading investments across a variety of companies, the fund helps mitigate individual company risk, thus appealing to investors seeking both growth opportunities and sector diversification.
The latest articles about FBT.
Both biotech ETFs hold about 30 healthcare names, but their index methods and fees differ enough to shape results for investors weighing sector exposure.
Fewer holdings, a higher fee, and a shallower drawdown set these two biotech funds apart in ways that could matter for long-term investors.
One fund holds about 60 drug companies at a lower fee. The other holds 30 biotech names and has a stronger long-term record. Either way, expect some volatility.
iShares offers lower fees and smoother returns, while First Trust provides concentrated biotech exposure with higher growth potential.
PINK offers broad active healthcare exposure with lower volatility, while FBT's concentrated biotech play delivered stronger 1-year returns but carries steeper drawdown risk.
FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.
Summary of Oct 24's posts. Generated by AI.
Summary of Sep 14's posts. Generated by AI.
No summary yet.
Investors talking about FBT also mention these. Each card shows that asset’s own numbers for the past 24 hours.